Richard B. Kim

Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance

Yan Zhang, Lei Zhang, K. Giacomini, 2018, Clinical pharmacology and therapeutics.

Grapefruit Juice Ingestion Significantly Reduces Talinolol Bioavailability

Wilhelm Kirch, W. Kirch, R. Kim, 2005, Clinical pharmacology and therapeutics.

Interindividual variability of chlorzoxazone 6‐hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms

R. Kim, G. Wilkinson, Richard B. Kim, 1995, Clinical pharmacology and therapeutics.

Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine

P. Dawson, R. Kim, U. Schwarz, 2002, Clinical pharmacology and therapeutics.

3‐Hydroxy‐3‐methylglutaryl–coenzyme a Reductase Inhibitors (statins) and Genetic Variability (Single Nucleotide Polymorphisms) in a Hepatic Drug Uptake Transporter: What's it all About?

R. Kim, Richard B. Kim, 2004, Clinical pharmacology and therapeutics.

Transporters and drug therapy: Implications for drug disposition and disease

R. Kim, Richard B. Kim, R. Ho, 2005, Clinical pharmacology and therapeutics.

Polymorphisms in Human MDR1 (P‐glycoprotein): Recent Advances and Clinical Relevance

Thierry Buclin, Catia Marzolini, T. Buclin, 2004, Clinical pharmacology and therapeutics.

P-glycoprotein Expression, Localization, and Function in Sandwich-Cultured Primary Rat and Human Hepatocytes: Relevance to the Hepatobiliary Disposition of a Model Opioid Peptide

K. Brouwer, K. Hoffmaster, P. Meier, 2004, Pharmaceutical Research.